Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 28, 2023
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
[ Tue, Mar 28th 2023
] - WOPRAI
Jay Olson Maintained (VKTX) at Buy with Increased Target to $30 on, Mar 28th, 2023
Jay Olson of Oppenheimer, Maintained "Viking Therapeutics, Inc." (VKTX) at Buy with Increased Target from $20 to $30 on, Mar 28th, 2023.
Jay has made no other calls on VKTX in the last 4 months.
There are 3 other peers that have a rating on VKTX. Out of the 3 peers that are also analyzing VKTX, 0 agree with Jay's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jay
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $21 on, Thursday, February 9th, 2023
- Steven Seedhouse of "Raymond James" Maintained at Buy with Increased Target to $12 on, Thursday, February 9th, 2023
- Naz Rahman of "Maxim Group" Maintained at Strong Buy with Increased Target to $15 on, Tuesday, December 20th, 2022
